Finance

Worth Comparing these two stocks: E.W. Scripps Company (The) (NASDAQ:SSP), TG Therapeutics, Inc. (NASDAQ:TGTX)

E.W. Scripps Company (The) (NASDAQ:SSP)

E.W. Scripps Company (The) (NASDAQ:SSP), ended its previous trading session at $7.85 showing a loss of -0.360000000000001 or -4.38 percent with respect to the price of $8.21 when stock market opened. The company traded 235562 shares over the course of the trading day. Giving the average volume of 475.1 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 81.08 Million.

E.W. Scripps Company (The) (NASDAQ:SSP) is currently trading lower than its price target which is set to $12.36 by the analyst. The stock is -53.85% Below its 1-Year High which is $17.01. SSP has a difference of 46.46% from its 1 year low which stands at $5.36. The company is currently rated by analyst who are keeping a close eye on the stock as 2.7. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.

E.W. Scripps Company (The) (NASDAQ:SSP) Performance Snapshot

E.W. Scripps Company (The) (NASDAQ:SSP) Price Insight

The stock needs to grow about $4.51 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are 3.13%, 2.33% and -35.5 percent respectively. The stock trades about 8.31 percent of its Float giving its total shares Outstanding are 81.08 Million. SSP lost about -46.31 percent in 6 months showing its Average True Range of 0.85. The company currently has a RSI and Beta of 51.5 and 1.83.

While talking about E.W. Scripps Company (The) (NASDAQ:SSP) valuation ratios, the stock trades with a P/S and P/B of 0.37 and 0.72 which is significantly better and attractive as compared to its peers.

TG Therapeutics, Inc. (NASDAQ:TGTX)

TG Therapeutics, Inc. (NASDAQ:TGTX), closed the last trading session at $20.99 with increase of $0.16 or 0.77 percent against the opening price of $20.83. The trading day volume of the company stands at 1.45 Million shares while the average trading volume of TG Therapeutics, Inc. (NASDAQ:TGTX) is 2.44 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 105.46 Million.

The price target of TG Therapeutics, Inc. (NASDAQ:TGTX) is currently set at 21.5 by the analysts. The stock is $-2.78 Below its 1-Year High which is $21.59. TGTX hit its 1-Year low price of $4.95. The company is currently rated by analyst who are keeping a close eye on the stock as 1.6. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.

Performance Indicators of TG Therapeutics, Inc. (NASDAQ:TGTX)

The value of the stock increased by 5.32% during the previous week performance. Looking at the 1 month performance of TG Therapeutics, Inc. (NASDAQ:TGTX), the stock jumped 66.46%. While the 1 year performance shows a positive percentage of 204.2 and year to date performance stands at 89.1%.

TG Therapeutics, Inc. (NASDAQ:TGTX) Analytical Review

The stock needs to grow about $0.510000000000002 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are 26.78%, 68.69% and 108.97 percent respectively. The stock trades about 12.29 percent of its Float giving its total shares Outstanding are 105.46 Million. TGTX gained about 164.69 percent in 6 months showing its Average True Range of 1.49. The company currently has a RSI and Beta of 69.7 and 2.09.

While talking about TG Therapeutics, Inc. (NASDAQ:TGTX) valuation ratios, the stock trades with a P/S and P/B of 12327.43 and 0 which is significantly better and attractive as compared to its peers.